MAX
Company Analysis Psychemedics Corporation
1. Summary
Advantages
- Price (2.67 $) is less than fair price (2.86 $)
- Current debt level 17.32% is below 100% and has decreased over 5 years from 37.08%.
Disadvantages
- Dividends (0%) are below the sector average (0.51%).
- The stock's return over the last year (0%) is lower than the sector average (22.65%).
- The company's current efficiency (ROE=-62.26%) is lower than the sector average (ROE=95.3%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Psychemedics Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -2.5% | -1.6% |
| 90 days | 0% | 3% | -4.5% |
| 1 year | 0% | 22.7% | 16.5% |
PMD vs Sector: Psychemedics Corporation has significantly underperformed the "Healthcare" sector by -22.65% over the past year.
PMD vs Market: Psychemedics Corporation has significantly underperformed the market by -16.47% over the past year.
Stable price: PMD is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: PMD with weekly volatility of 0% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (2.67 $) is lower than the fair price (2.86 $).
Price not significantly lower than the fair price: The current price (2.67 $) is slightly lower than the fair price by 7.1%.
5.2. P/E
P/E vs Sector: The company's P/E (-3.69) is lower than that of the sector as a whole (26.63).
P/E vs Market: The company's P/E (-3.69) is higher than that of the market as a whole (-88.36).
5.3. P/BV
P/BV vs Sector: The company's P/BV (2.43) is lower than that of the sector as a whole (244.09).
P/BV vs Market: The company's P/BV (2.43) is lower than that of the market as a whole (81.84).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0.74) is lower than that of the sector as a whole (128.13).
P/S vs Market: The company's P/S indicator (0.74) is lower than that of the market as a whole (116.29).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-66.05) is lower than that of the sector as a whole (-21.78).
EV/Ebitda vs Market: The company's EV/Ebitda (-66.05) is higher than that of the market as a whole (-79.49).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 104.93% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (104.93%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-28.94%).
6.4. ROE
ROE vs Sector: The company's ROE (-62.26%) is lower than that of the sector as a whole (95.3%).
ROE vs Market: The company's ROE (-62.26%) is lower than that of the market as a whole (23.33%).
6.6. ROA
ROA vs Sector: The company's ROA (-31.3%) is lower than that of the sector as a whole (-4.47%).
ROA vs Market: The company's ROA (-31.3%) is lower than that of the market as a whole (4.25%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is higher than that of the sector as a whole (-0.11%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.8%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.51%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.64.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Based on sources: porti.ru
